TransEnterix CEO steps down amid company's financial struggles
The CEO of a Triangle bio-tech firm is stepping down as the company continues to look for ways to finance its operations beyond the first quarter of next year.
Research Triangle Park-based TransEnterix (NYSE: TRXC) has announced its long-time president and CEO – Todd Pope – is stepping down effective immediately.
According to a company statement, Pope will remain on as a "senior advisor to the company."
Pope served as CEO since 2008. His base sa lary in 2018 was $480,800, according to the…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news
More News: Biotechnology | Health Management